These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 20057389)

  • 1. Biomarkers still off the mark for detecting breast cancer.
    May M
    Nat Med; 2010 Jan; 16(1):3. PubMed ID: 20057389
    [No Abstract]   [Full Text] [Related]  

  • 2. Breast cancer screening and biomarkers.
    Brooks M
    Methods Mol Biol; 2009; 472():307-21. PubMed ID: 19107439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical value of serum tumour markers TPA, TPS, TAG 12, CA 15-3 and MCA in breast cancer diagnosis; results from a prospective study.
    Eskelinen M; Hippeläinen M; Kettunen J; Salmela E; Penttilä I; Alhava E
    Anticancer Res; 1994; 14(2B):699-703. PubMed ID: 8010729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Found in transcription: gene expression and other novel blood biomarkers for the early detection of breast cancer.
    Lönneborg A; Aarøe J; Dumeaux V; Børresen-Dale AL
    Expert Rev Anticancer Ther; 2009 Aug; 9(8):1115-23. PubMed ID: 19671031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Biomarkers in breast cancer].
    Kurebayashi J
    Gan To Kagaku Ryoho; 2004 Jul; 31(7):1021-6. PubMed ID: 15272579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cytokines as tumor markers in breast cancer].
    Ławicki S; Mroczko B; Szmitkowski M
    Postepy Hig Med Dosw; 2003; 57(4):455-63. PubMed ID: 14626202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study for clinical usefulness of CEA, TPA, CA15-3 and BCA225 in breast cancer].
    Kaneko Y; Imoto S; Kasakura S
    Rinsho Byori; 1995 Jul; 43(7):696-702. PubMed ID: 7674542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical evaluation of a new tumour marker TAG 12 in breast cancer.
    Eskelinen M; Hippeläinen M; Carlsson L; Jonsson P
    Anticancer Res; 1991; 11(2):805-8. PubMed ID: 2064336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical utility of the combined use of plurime tumor markers in human breast cancer.
    Neri B; Bartalucci S; Cataliotti L; Distante V; Tommasi M; Ciapini A
    Cancer Detect Prev; 1988; 13(2):115-21. PubMed ID: 3072081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new tumor marker MCA in breast cancer diagnosis.
    Eskelinen M; Tikanoja S; Collan Y
    Anticancer Res; 1988; 8(4):665-8. PubMed ID: 3178156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of breast cancer and lymph node metastatic status with tumour markers using logistic regression models.
    Hwa HL; Kuo WH; Chang LY; Wang MY; Tung TH; Chang KJ; Hsieh FJ
    J Eval Clin Pract; 2008 Apr; 14(2):275-80. PubMed ID: 18284517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical usefulness of tumor markers in breast cancer].
    Konishi K; Karaki K; Watanabe K; Tsuda H; Konishi F
    Rinsho Byori; 1993 Oct; 41(10):1108-15. PubMed ID: 8254956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tumor markers in breast cancer].
    Harada Y; Ohuchi N; Ishida T; Ohnuki K
    Gan To Kagaku Ryoho; 2001 Jul; 28(7):1035-40. PubMed ID: 11478135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tumor markers in breast cancer].
    Kurebayashi J
    Gan To Kagaku Ryoho; 2004 Nov; 31(12):2077-81. PubMed ID: 15570944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumour markers in breast cancer--EGTM recommendations. European Group on Tumor Markers.
    Anticancer Res; 1999; 19(4A):2803-5. PubMed ID: 10470245
    [No Abstract]   [Full Text] [Related]  

  • 16. Serum tumour markers CEA, AFP, CA 15-3, TPS and Neu in diagnosis of breast cancer.
    Eskelinen M; Kataja V; Hämäläinen E; Kosma VM; Penttilä I; Alhava E
    Anticancer Res; 1997; 17(2B):1231-4. PubMed ID: 9137478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Old and new markers for breast cancer prognosis: the need for integrated research on quantitative issues.
    Biganzoli E; Boracchi P
    Eur J Cancer; 2004 Aug; 40(12):1803-6. PubMed ID: 15288279
    [No Abstract]   [Full Text] [Related]  

  • 18. High-throughput genomic technology in research and clinical management of breast cancer. Plasma-based proteomics in early detection and therapy.
    Davis MA; Hanash S
    Breast Cancer Res; 2006; 8(6):217. PubMed ID: 17184556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibodies in breast cancer sera: candidate biomarkers and reporters of tumorigenesis.
    Fernández Madrid F
    Cancer Lett; 2005 Dec; 230(2):187-98. PubMed ID: 16297705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serological tumor markers for monitoring breast cancer.
    Sölétormos G
    Dan Med Bull; 2001 Nov; 48(4):229-55. PubMed ID: 11767127
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.